Specify a stock or a cryptocurrency in the search bar to get a summary
CytoTools AG
T5ObioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. The company was founded in 2000 and is based in Darmstadt, Germany. Address: , Darmstadt, Germany, 64295
Analytics
WallStreet Target Price
2.88 EURP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures T5O
Dividend Analytics T5O
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History T5O
Stock Valuation T5O
Financials T5O
Results | 2019 | Dynamics |